Annual EBITDA
-$44.44 M
-$10.36 M-30.42%
December 31, 2023
Summary
- As of February 7, 2025, CRBP annual EBITDA is -$44.44 million, with the most recent change of -$10.36 million (-30.42%) on December 31, 2023.
- During the last 3 years, CRBP annual EBITDA has risen by +$76.68 million (+63.31%).
- CRBP annual EBITDA is now -7875.00% below its all-time high of -$557.20 thousand, reached on December 31, 2013.
Performance
CRBP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$13.25 M
-$4.06 M-44.10%
September 30, 2024
Summary
- As of February 7, 2025, CRBP quarterly EBITDA is -$13.25 million, with the most recent change of -$4.06 million (-44.10%) on September 30, 2024.
- Over the past year, CRBP quarterly EBITDA has dropped by -$1.97 million (-17.51%).
- CRBP quarterly EBITDA is now -760.95% below its all-time high of $2.00 million, reached on June 30, 2019.
Performance
CRBP Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$43.19 M
-$4.33 M-11.14%
September 30, 2024
Summary
- As of February 7, 2025, CRBP TTM EBITDA is -$43.19 million, with the most recent change of -$4.33 million (-11.14%) on September 30, 2024.
- Over the past year, CRBP TTM EBITDA has increased by +$1.74 million (+3.87%).
- CRBP TTM EBITDA is now -85938.84% below its all-time high of -$50.20 thousand, reached on September 30, 2013.
Performance
CRBP TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CRBP EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -30.4% | -17.5% | +3.9% |
| 3 y3 years | +63.3% | -183.5% | -53.2% |
| 5 y5 years | +21.0% | -183.5% | -53.2% |
CRBP EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -30.4% | +18.2% | -183.5% | +22.6% | -53.2% | +20.5% |
| 5 y | 5-year | -30.4% | +63.3% | -183.5% | +64.8% | -53.2% | +66.1% |
| alltime | all time | -7875.0% | +63.3% | -761.0% | +64.8% | <-9999.0% | +66.1% |
Corbus Pharmaceuticals Holdings EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$13.25 M(+44.1%) | -$43.19 M(+11.1%) |
| Jun 2024 | - | -$9.19 M(-2.9%) | -$38.86 M(+4.2%) |
| Mar 2024 | - | -$9.47 M(-16.0%) | -$37.28 M(-17.0%) |
| Dec 2023 | -$44.44 M(+30.4%) | -$11.28 M(+26.4%) | -$44.93 M(+17.2%) |
| Sep 2023 | - | -$8.92 M(+17.1%) | -$38.33 M(+2.3%) |
| Jun 2023 | - | -$7.62 M(-55.5%) | -$37.46 M(+1.3%) |
| Mar 2023 | - | -$17.12 M(+266.2%) | -$36.99 M(+31.2%) |
| Dec 2022 | -$34.07 M(-37.3%) | -$4.67 M(-41.9%) | -$28.19 M(-14.6%) |
| Sep 2022 | - | -$8.05 M(+12.6%) | -$33.03 M(-14.3%) |
| Jun 2022 | - | -$7.15 M(-14.1%) | -$38.55 M(-19.2%) |
| Mar 2022 | - | -$8.32 M(-12.5%) | -$47.68 M(-12.3%) |
| Dec 2021 | -$54.35 M(-55.1%) | -$9.51 M(-29.9%) | -$54.35 M(-16.7%) |
| Sep 2021 | - | -$13.57 M(-16.7%) | -$65.22 M(-23.5%) |
| Jun 2021 | - | -$16.28 M(+8.6%) | -$85.28 M(-20.1%) |
| Mar 2021 | - | -$14.99 M(-26.5%) | -$106.68 M(-11.9%) |
| Dec 2020 | -$121.12 M(+59.6%) | -$20.38 M(-39.4%) | -$121.12 M(-5.0%) |
| Sep 2020 | - | -$33.63 M(-10.7%) | -$127.52 M(+7.4%) |
| Jun 2020 | - | -$37.68 M(+28.0%) | -$118.70 M(+50.2%) |
| Mar 2020 | - | -$29.43 M(+9.9%) | -$79.02 M(+4.1%) |
| Dec 2019 | -$75.87 M | -$26.79 M(+7.9%) | -$75.87 M(+14.1%) |
| Sep 2019 | - | -$24.81 M(-1337.8%) | -$66.53 M(+17.8%) |
| Jun 2019 | - | $2.00 M(-107.6%) | -$56.48 M(-20.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$26.28 M(+50.7%) | -$70.88 M(+26.5%) |
| Dec 2018 | -$56.25 M(+74.1%) | -$17.44 M(+18.1%) | -$56.04 M(+13.4%) |
| Sep 2018 | - | -$14.77 M(+19.1%) | -$49.41 M(+19.1%) |
| Jun 2018 | - | -$12.39 M(+8.3%) | -$41.47 M(+14.1%) |
| Mar 2018 | - | -$11.45 M(+6.0%) | -$36.34 M(+12.5%) |
| Dec 2017 | -$32.31 M(+62.4%) | -$10.80 M(+58.1%) | -$32.31 M(+11.2%) |
| Sep 2017 | - | -$6.83 M(-5.9%) | -$29.05 M(+5.5%) |
| Jun 2017 | - | -$7.26 M(-2.2%) | -$27.54 M(+12.6%) |
| Mar 2017 | - | -$7.42 M(-1.6%) | -$24.45 M(+22.9%) |
| Dec 2016 | -$19.90 M(+125.9%) | -$7.54 M(+42.0%) | -$19.90 M(+34.1%) |
| Sep 2016 | - | -$5.31 M(+27.4%) | -$14.84 M(+26.1%) |
| Jun 2016 | - | -$4.17 M(+45.4%) | -$11.76 M(+15.9%) |
| Mar 2016 | - | -$2.87 M(+15.6%) | -$10.15 M(+15.2%) |
| Dec 2015 | -$8.81 M(+251.5%) | -$2.48 M(+10.8%) | -$8.81 M(+16.2%) |
| Sep 2015 | - | -$2.24 M(-12.4%) | -$7.58 M(+26.5%) |
| Jun 2015 | - | -$2.56 M(+67.2%) | -$5.99 M(+52.5%) |
| Mar 2015 | - | -$1.53 M(+22.0%) | -$3.93 M(+56.8%) |
| Dec 2014 | -$2.51 M(+349.8%) | -$1.25 M(+91.7%) | -$2.51 M(+64.0%) |
| Sep 2014 | - | -$654.10 K(+32.6%) | -$1.53 M(+65.3%) |
| Jun 2014 | - | -$493.20 K(+370.6%) | -$924.30 K(+114.4%) |
| Mar 2014 | - | -$104.80 K(-62.0%) | -$431.10 K(+32.1%) |
| Dec 2013 | -$557.20 K | -$276.10 K(+450.0%) | -$326.30 K(+550.0%) |
| Sep 2013 | - | -$50.20 K | -$50.20 K |
FAQ
- What is Corbus Pharmaceuticals Holdings annual EBITDA?
- What is the all time high annual EBITDA for Corbus Pharmaceuticals Holdings?
- What is Corbus Pharmaceuticals Holdings annual EBITDA year-on-year change?
- What is Corbus Pharmaceuticals Holdings quarterly EBITDA?
- What is the all time high quarterly EBITDA for Corbus Pharmaceuticals Holdings?
- What is Corbus Pharmaceuticals Holdings quarterly EBITDA year-on-year change?
- What is Corbus Pharmaceuticals Holdings TTM EBITDA?
- What is the all time high TTM EBITDA for Corbus Pharmaceuticals Holdings?
- What is Corbus Pharmaceuticals Holdings TTM EBITDA year-on-year change?
What is Corbus Pharmaceuticals Holdings annual EBITDA?
The current annual EBITDA of CRBP is -$44.44 M
What is the all time high annual EBITDA for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high annual EBITDA is -$557.20 K
What is Corbus Pharmaceuticals Holdings annual EBITDA year-on-year change?
Over the past year, CRBP annual EBITDA has changed by -$10.36 M (-30.42%)
What is Corbus Pharmaceuticals Holdings quarterly EBITDA?
The current quarterly EBITDA of CRBP is -$13.25 M
What is the all time high quarterly EBITDA for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high quarterly EBITDA is $2.00 M
What is Corbus Pharmaceuticals Holdings quarterly EBITDA year-on-year change?
Over the past year, CRBP quarterly EBITDA has changed by -$1.97 M (-17.51%)
What is Corbus Pharmaceuticals Holdings TTM EBITDA?
The current TTM EBITDA of CRBP is -$43.19 M
What is the all time high TTM EBITDA for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high TTM EBITDA is -$50.20 K
What is Corbus Pharmaceuticals Holdings TTM EBITDA year-on-year change?
Over the past year, CRBP TTM EBITDA has changed by +$1.74 M (+3.87%)